In this episode of Captivating Health Insights, host Maddison Bezdicek continues her conversation with Kevin Kobielski, President and Founder of Navion, diving deeper into the contract mechanics and procurement strategies that shape pharmacy benefit management (PBM) outcomes for self-funded employers.
Kobielski explains how audit rights, market checks, and contract language affect plan savings and accountability. The episode also explores alternative drug sourcing strategies—including Cost Plus Drugs, 340B programs, and manufacturer assistance plans—and what employers need to know about their adoption challenges. This is Part 2 of a two-part discussion.
Chapters
(00:00:00) - Audit rights in PBM contracts(00:00:21) - Mark Cuban's "Cost-Plus Drugs" program(00:04:11) - 340b pharmacies(00:10:21) - PBM contracts & looking at the optics(00:14:40) - Audit rights in PBM contracts(00:17:08) - Market checks for PBM contracts(00:19:15) - PBM comparisons(00:20:47) - Kevin's take on what's head for PBMs(00:23:18) - Navion's PBM analysis approach(00:26:55) - Wrap up

Ver todos los episodios